Physician

Subramaniam Anandasivam, MD PA

According to 2025 Medicare claims, Subramaniam Anandasivam, MD PA (NPI: 1972560522) practices nephrology in the Brownsville-Harlingen, TX market, with the plurality of this provider's patient population coming from Cameron, TX. This provider's primary affiliated billing organization is SUBRA ANANDASIVAM MD PA (NPI: 1710270657; TIN: 742958441) and primary practice location at 78521-2459.

Anandasivam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 242 traditional Medicare patients, billed 1,884 HCPCS/CPT codes, and received $235,289 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,598 prescription claims across 439 beneficiaries totaling $2,194,869 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). 2023 DME data shows 50 claims. Open Payments data shows 16 records totaling $424. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $883,812 to $235,289. In contrast, Part D prescription costs have risen steadily, from $1,285,260 to $2,194,869. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	816	8,302	$883,812
2016	796	7,098	$807,955
2017	842	7,095	$831,045
2018	732	6,675	$817,431
2019	666	6,270	$810,426
2020	624	5,744	$715,555
2021	448	3,719	$599,959
2022	363	2,866	$453,938
2023	299	2,382	$340,462
2024	242	1,884	$235,289

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	665	5,789	$1,285,260
2016	636	5,619	$1,855,220
2017	670	5,486	$1,948,524
2018	645	4,832	$1,364,409
2019	550	3,883	$1,214,859
2020	505	3,702	$1,524,352
2021	409	2,979	$1,834,452
2022	427	2,905	$2,064,319
2023	417	2,668	$2,186,540
2024	439	2,598	$2,194,869

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	174	$22,247
2016	N/R	190	$17,294
2017	N/R	209	$16,903
2018	N/R	156	$14,306
2019	N/R	120	$10,152
2020	N/R	116	$9,304
2021	N/R	96	$7,893
2022	N/R	N/R	N/R
2023	N/R	50	$1,394
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	79	544	$240
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	66	160	$201
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	57	102	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	89	202	$82
90935	Hemodialysis procedure with physician evaluation	79	600	$49

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	313	13,460	$1,026,313
Auryxia	Ferric Citrate	151	9,570	$486,139
Kerendia	Finerenone	310	20,720	$428,804
Sevelamer Carbonate	Sevelamer Carbonate	176	11,750	$57,680
Veltassa	Patiromer Calcium Sorbitex	33	1,230	$39,374

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$424	Fresenius USA Marketing, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Subramaniam Anandasivam, MD PA?

Tedicare shows public-source Medicare data for Subramaniam Anandasivam, MD PA (NPI 1972560522), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Subramaniam Anandasivam, MD PA have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Subramaniam Anandasivam, MD PA?

Subramaniam Anandasivam, MD PA is linked to SUBRA ANANDASIVAM MD PA (billing NPI 1710270657) in the available physician profile data.

Does Subramaniam Anandasivam, MD PA have Open Payments data?

Subramaniam Anandasivam, MD PA has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.